# Phase 2.11: Regional & Nationwide Expansion Benchmark Report

**Generated:** 2026-11-06T16:16:04Z
**Target System:** Lungent Regional & Nationwide Expansion Architecture
**Environment:** Simulated Multi-Tier Bangladesh Healthcare Network (8 Divisions, 5 Facility Tiers)

## 1. Executive Summary

Phase 2.11 establishes the operational, architectural, and governance infrastructure required for regional and nationwide scaling of the Lungent clinical decision-support platform. The benchmarking suite confirms high throughput across multi-tier onboarding, sub-millisecond referral pathway routing, robust monitoring throughput across distributed health nodes, 100% Zero-PHI compliance, and an 8-step rollout governance gate.

## 2. Benchmark Evaluation Results

### A. Regional Facility Onboarding Scaling
- **Total Facilities Onboarded:** 250
- **Onboarding Processing Duration:** 0.33 ms
- **Mean Facility Readiness Score:** 81.94 / 100 (Std Dev: 17.36)
- **Active Operational Facilities:** 200 (80.0%)
- **Pending Verification Facilities:** 44
- **Draft Status Facilities:** 6
- **DGHS Facility Code Collisions Intercepted:** 4 (100% collision prevention)

### B. Regional Hub-and-Spoke Referral Routing
- **Total Cross-Facility Referral Requests:** 1000
- **Routing Duration:** 0.14 ms
- **Mean Latency per Routing Decision:** 0.14 microseconds (< 0.05 ms SLA)
- **Authorized Disclosures:** 850 (85.0%)
- **Denied Disclosures (Missing Consent):** 150
- **Mean Escalation Hops:** 1.2 (Max Hops: 2)
- **Consent Gate Verification Accuracy:** 100.0%

### C. Centralized Subsystem Health Monitoring
- **Distributed Health Nodes Probed:** 50
- **Total Subsystem Probes Executed:** 350
- **Probe Execution Throughput:** 988817.8 probes/second
- **Mean Subsystem Latency:** 27.14 ms
- **Subsystem Healthy Ratio:** 100.0%

### D. Strict Zero-PHI Invariant Security Audit
- **Telemetry Logs Audited:** 500
- **PHI-Bearing Logs Intercepted:** 375 of 375
- **Clean Operational Logs Permitted:** 125 of 125
- **Detection Sensitivity:** 100.0%
- **Detection Specificity:** 100.0%
- **PHI Leakage Rate:** 0.0% (0 leaked records)
- **Zero-PHI Invariant Status:** SATISFIED (PASS)

### E. Phased Rollout Management & Deployment Gating
- **Phased Rollout Milestones:** 5 of 8 completed (62.5%)
- **Current Operational Phase:** Controlled Regional Expansion Active (5 of 8 Completed)
- **Current Nationwide Rollout Authorization:** BLOCKED (Pending Milestones 6–8)
- **Prerequisite Enforcement:** Fully Enforced

## 3. Conclusion & Expansion Readiness

The Lungent Phase 2.11 Regional & Nationwide Expansion architecture satisfies all technical, clinical safety, interoperability, and security benchmarks. Ready for progression to formal clinical and governance milestones.
